Advanced search
Publication Cover
Cell Cycle Volume 19, 2020 - Issue 21
Submit an article Journal homepage
792
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3

Zhiyang Lia Department of Breast Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China;b Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaORCID Iconhttps://orcid.org/0000-0002-5481-3985View further author information
ORCID Icon,
Jiehua Zhengb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Weixun Linb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Jiaquan Wengb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Weida Hongb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Juan Zoub Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Taofeng Zhangb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
,
Changsheng Yea Department of Breast Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
View further author information
&
Yexi Chenb Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, ChinaView further author information
 show all
Pages 2811-2825 | Received 13 May 2020, Accepted 26 Aug 2020, Published online: 15 Oct 2020

References

  • Adeloye D, Sowunmi OY, Jacobs W, et al. Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010419
  • McAnena PF, McGuire A, Ramli A, et al. Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. BMC Cancer. 2018;18(1):203
  • Harbeck N, Penault-Llorca F, Cortes J, et al. Breast cancer. Nat Rev. 2019;5(1):66.
  • Mitra S, Dash R. Natural products for the management and prevention of breast cancer. Evidence-Based Complementary Altern Med. 2018;2018:8324696.
  • Power EJ, Chin ML, Haq MM. Breast cancer incidence and risk reduction in the hispanic population. Cureus. 2018;10(2):e2235.
  • Hu W, Tan C, He Y, et al. Functional miRNAs in breast cancer drug resistance. Onco Targets Ther. 2018;11:1529.
  • Lai Z, Yang Y, Yan Y, et al. Analysis of co-expression networks for circular RNAs and mRNAs reveals that circular RNAs hsa_circ_0047905, hsa_circ_0138960 and has-circRNA7690-15 are candidate oncogenes in gastric cancer. Cell Cycle. 2017;16(23):2301–2311
  • Jiang L, Sun D, Hou J, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7
  • Guo JU, Agarwal V, Guo H, et al. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409
  • Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. Rna. 2013;19(2):141–157
  • Lü L, Sun J, Shi P, et al. Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer. Oncotarget. 2017;8(27):44096
  • Wang N, Gu Y, Li L, et al. Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Arch Biochem Biophys. 2018;653:63–70.
  • Huang X, Xie X, Wang H, et al. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res. 2017;36(1):1–12
  • Yin WB, Yan MG, Fang X, et al. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta. 2018;487:363–368.
  • Yu J, Yang M, Zhou B, et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway. Clin Sci. 2019;133(13):1487–1503
  • Sasi W, Jiang WG, Sharma A, et al. Higher expression levels of SOCS 1, 3, 4, 7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer. 2010;10(1):178.
  • Pichler M, Calin GA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113(4):569–573.
  • Bartel DP. Metazoan microRNAs. Cell. 2018;173(1):20–51.
  • Wang X, Fang L. Advances in circular RNAs and their roles in breast Cancer. J Exp Clin Cancer Res. 2018;37(1):206.
  • Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358
  • Wang H, Xiao YI, Wu LI, et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J Oncol. 2018;52(3):743–754.
  • He R, Liu P, Xie X, et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res. 2017;36(1):145
  • Gao D, Zhang X, Liu B, et al. Screening circular RNA related to chemotherapeutic resistance in breast cancer. Epigenomics. 2017;9(9):1175–1188
  • Hua Z, Ma K, Liu S, et al. LncRNA ZEB1-AS1 facilitates ox-LDL-induced damage of HCtAEC cells and the oxidative stress and inflammatory events of THP-1 cells via miR-942/HMGB1 signaling. Life Sci. 2020;247:117334.
  • Shan Z, An N, Qin J, et al. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signaling. Biomed Pharmacother. 2018;101:769–776.
  • Xie J, Wang S, Li G, et al. circEPSTI1 regulates ovarian cancer progression via decoying miR-942. J Cell Mol Med. 2019;23(5):3597–3602
  • Zhang J, Zhang Z, Sun J, et al. MiR-942 regulates the function of breast cancer cell by targeting FOXA2. Biosci Rep. 2019;39(11):BSR20192298
  • Xu JZ, Shao CC, Wang XJ, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):1–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.